文献速递腹部技术与安全US

超声影像组学鉴别感染性局灶性肝病变与恶性肿瘤

Differentiating infected focal liver lesions from malignant mimickers: value of ultrasound-based radiomics.
PubMed 文献 · Clin Radiol · 2021-11-06

本研究纳入104例感染性局灶性肝病变和485例恶性肝肿瘤患者,从灰阶超声图像提取影像组学特征并通过机器学习建模。模型在训练集和验证集中对鉴别感染性病变与恶性肝肿瘤均显示出较好的预测价值,AUC分别为0.949和0.745(恶性肝肿瘤组)。结论认为超声影像组学可作为常规灰阶超声和超声造影的补充工具。

要点

  • 超声影像组学模型有助于鉴别感染性局灶性肝病变与恶性肝肿瘤。
  • 模型对恶性肝肿瘤组的AUC在训练集为0.949,验证集为0.745。
  • 该模型有潜力作为常规灰阶超声和超声造影的补充。

核心结论

  • 基于超声的影像组学有助于鉴别感染性局灶性肝病变与恶性模仿病变,有潜力作为常规灰阶超声和超声造影的补充。

研究设计与样本

  • 研究纳入104例感染性局灶性肝病变患者和485例恶性肝肿瘤患者,恶性肝肿瘤包括肝细胞癌、胆管癌、混合型肝细胞-胆管癌和肝转移。

诊断标准与关键数值

  • 从每个局灶性肝病变的灰阶超声图像中提取5234个影像组学特征。
  • 模型鉴别感染性病变与恶性肝肿瘤的AUC在训练集为0.949、验证集为0.745。
  • 模型鉴别感染性病变与肝细胞癌的AUC在训练集为0.887、验证集为0.836。
  • 模型鉴别感染性病变与胆管癌的AUC在训练集为0.896、验证集为0.766。
  • 模型鉴别感染性病变与混合型肝细胞-胆管癌的AUC在训练集为0.944、验证集为0.754;与肝转移的AUC在训练集为0.918、验证集为0.808。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To establish an ultrasound-based radiomics model through machine learning methods and then to assess the ability of the model to differentiate infected focal liver lesions from malignant mimickers.

MATERIALS AND METHODS: A total of 104 patients with infected focal liver lesions and 485 patients with malignant hepatic tumours were included, consisting of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), combined hepatocellular-cholangiocarcinoma (cHCC-CC), and liver metastasis. Radiomics features were extracted from grey-scale ultrasound images. Feature selection and predictive modelling were carried out by dimensionality reduction methods and classifiers. The diagnostic effect of the prediction mode was assessed by receiver operating characteristic (ROC) curve analysis.

RESULTS: In total, 5,234 radiomics features were extracted from grey-scale ultrasound image of every focal liver lesion. The ultrasound-based radiomics model had a favourable predictive value for differentiating infected focal liver lesions from malignant hepatic tumours, with an area under the curve (AUC) of 0.887 and 0.836 (HCC group), 0.896 and 0.766 (CC group), 0.944 and 0.754 (cHCC-CC group), 0.918 and 0.808 (liver metastasis group), and 0.949 and 0.745 (malignant hepatic tumour group) for the training set and validation set, respectively.

CONCLUSIONS: Ultrasound-based radiomics is helpful in differentiating infected focal liver lesions from malignant mimickers and has the potential for use as a supplement to conventional grey-scale ultrasound and contrast-enhanced ultrasound (CEUS).

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Peng, Peng, Lin, et al. Differentiating infected focal liver lesions from malignant mimickers: value of ultrasound-based radiomics. Clin Radiol. 2021. PMID: 34753587. doi:10.1016/j.crad.2021.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。